Loblaw Companies Limited

Loblaw Companies Limited

LBLCF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$53.19B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Loblaw Companies LimitedLoblaw Companies Limited29.30.85%28%0.90.1

Earnings Call Q3 2026

November 19, 2026 - AI Summary

Q3 earnings growth was strong on margins, but consolidated EPS was dragged by EQ Bank timing (GOOD/BAD): Retail sales rose CAD 700 million, up 3.6% to CAD 19.9 billion, retail adjusted EBITDA rose 6.9% with margin +30 basis points, and retail adjusted diluted EPS from continuing operations rose 15.6%. However, consolidated adjusted EPS rose only 8.8% because the EQ Bank deal closed July 1, 2026 and Q3 includes only 1 month of its earnings (CAD 9 million) due to reporting-calendar differences; management said with a full quarter EPS growth would have been low-double-digits, with full-quarter contribution from Q4 2026 onwards. GAAP diluted EPS was CAD 1.03, including a CAD 400 million post-tax gain from the sale of PC Financial. Gross margin was stable +20 basis points to 31.3% on high-growth complementary businesses and shrink, and SG&A improved 20 basis points to 20.0% despite new stores and ramp-up of an automated distribution facility, showing operating leverage.
Food was soft, Drug/Pharmacy and Online were the drivers (MIXED): Food absolute sales rose 2.8% but same-store sales rose only 0.6%, with traffic softening; hard discount banners comped above 2% and conventional banners improved after lapping strong prior-year comps, and Loblaw gained market share with internal food inflation in line with Canada's grocery CPI. Drug retail sales rose 5.7% with same-store sales up 4.8%, led by pharmacy and healthcare services up 7.6% on specialty and chronic prescriptions and, increasingly, generic GLP-1 drugs where lower price points are expanding the overall category - marginally helping gross margin in Q3, with more expected in 2027. Shoppers front-store same-store sales rose 1.6% on beauty and OTC. Online sales grew 16.9% via PC Express and delivery partners, and high-growth complementary businesses grew high double-digits.
Full-year 2026 outlook reaffirmed, Q4 trending better, but 2027 is the risk year (FORECAST/CHALLENGES): Management reiterated it expects retail earnings to grow faster than sales and adjusted EPS to grow high single-digits for 2026, including only 1 month of EQ Bank in Q3 and excluding the 53rd week last year, and said Q4 food same-store sales are currently trending higher than Q3, though the holiday season is key and unpredictable. Capital expenditure is planned at ~CAD 2.4 billion this year for stores and distribution, with CapEx expected to decline in 2027. The main forward risks are supplier price increases: big CPGs are requesting increases above inflation that management is pushing back on as unjustified, and vendors who hedged 2026 are now hedging at much higher levels, so pressure is expected to filter through more in 2027. No dividend was discussed.

Exclusive for Stockcircle Pro members

Sign upSign Up
$49.58

Current Fair Value

0.4% downside

Overvalued by 0.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$53.19 Billion
Enterprise Value$53.79 Billion
Annual dividend$0.43
Dividend yield0.85%
Earnings per Share$2.24
Beta0.41
Outstanding Shares1,159,600,000

Return

Return on Equity27.67%ROE
Return on Assets8.25%
Return on Invested Capital15.94%

Valuation & Multiples

P/E Ratio29.26P/E Ratio
PEG58.23PEG
Price to Sales0.89Price to Sales
Price to Book Ratio4.98Price to Book Ratio
Enterprise Value to Revenue0.83
Enterprise Value to EBIT11.73
Enterprise Value to Net Income16
Total Debt to Enterprise0.03
Debt to Equity0.14Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 19, 2026
EPS
$0.53
Est. $0.52
Revenue
$13.95 B
Est. $13.95 B

Next Earnings Call

Expected Date
February 25, 2027
EPS Estimate
$0.45
Consensus analyst estimate
Revenue Estimate
$11.02 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Loblaw Companies Limited

220,000 employees
CEO: Per Bank

Loblaw Companies Limited operates as a prominent Canadian corporation, primarily focused on the food and pharmaceutical sectors. Its extensive business activities across Canada encompass grocery retail, pharmacy services, health and beau...